Brian J Czerniecki Selected Research

BM 27

1/2022

The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian J Czerniecki Research Topics

Disease

63	Neoplasms (Cancer) 01/2022 - 05/2002
60	Breast Neoplasms (Breast Cancer) 04/2022 - 03/2002
16	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019 - 02/2007
14	Melanoma (Melanoma, Malignant) 01/2022 - 05/2002
6	Carcinoma (Carcinomatosis) 01/2022 - 04/2005
6	Pathologic Complete Response 01/2022 - 05/2015
4	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 09/2009
3	Neoplasm Metastasis (Metastasis) 04/2022 - 09/2006
3	Brain Neoplasms (Brain Tumor) 11/2021 - 03/2021
3	Carcinogenesis 02/2017 - 01/2009
2	Triple Negative Breast Neoplasms 09/2019 - 05/2018
2	Necrosis 09/2013 - 05/2009
1	Neutropenia 11/2021
1	Breast Diseases (Breast Disease) 01/2021
1	Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary) 01/2021
1	Colonic Neoplasms (Colon Cancer) 10/2018
1	Second Primary Neoplasms (Neoplasms, Second) 06/2017
1	Experimental Melanoma 02/2016
1	Barrett Esophagus (Barrett's Esophagus) 01/2016

Drug/Important Bio-Agent (IBA)

26	VaccinesIBA 01/2021 - 09/2003
15	Peptides (Polypeptides)IBA 01/2022 - 05/2002
13	CytokinesIBA 01/2021 - 08/2006
11	AntigensIBA 09/2021 - 05/2002
8	Trastuzumab (Herceptin)FDA Link 06/2019 - 10/2009
6	Estrogen ReceptorsIBA 06/2017 - 05/2009
5	human ERBB2 proteinIBA 04/2022 - 05/2015
5	Estrogens (Estrogen)FDA Link 07/2020 - 09/2012
5	Hemoglobins (Hemoglobin)IBA 05/2015 - 04/2005
4	EpitopesIBA 01/2022 - 05/2002
4	Proteins (Proteins, Gene)FDA Link 09/2021 - 08/2014
4	Interferon-gamma (Interferon, gamma)IBA 01/2021 - 05/2002
4	Phosphotransferases (Kinase)IBA 10/2019 - 01/2010
4	Biomarkers (Surrogate Marker)IBA 10/2017 - 10/2011
4	Interleukin-12 (IL 12)IBA 11/2011 - 09/2003
3	AntibodiesIBA 01/2022 - 02/2007
3	ChemokinesIBA 01/2022 - 09/2009
3	Pharmaceutical PreparationsIBA 01/2021 - 12/2014
3	InterferonsIBA 01/2021 - 01/2012
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2010
3	tyrosine receptor (receptor, tyrosine)IBA 01/2019 - 01/2010
3	Epidermal Growth Factor (EGF)IBA 10/2017 - 10/2013
3	ErbB-2 ReceptorIBA 11/2014 - 07/2007
3	Cancer VaccinesIBA 10/2012 - 04/2008
2	Hormones (Hormone)IBA 11/2021 - 09/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2017
2	Monoclonal AntibodiesIBA 01/2020 - 10/2018
2	pertuzumabIBA 10/2018 - 05/2018
2	Complement System Proteins (Complement)IBA 05/2015 - 02/2007
2	sipuleucel-T (APC8015)FDA Link 01/2015 - 12/2014
2	Interleukin-17 (Interleukin 17)IBA 11/2013 - 10/2008
2	Hypochlorous Acid (Hypochlorite)IBA 09/2013 - 11/2011
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2012 - 03/2006
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2011 - 05/2009
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2011 - 09/2003
2	Biological ProductsIBA 04/2008 - 11/2006
2	Coloring Agents (Dyes)IBA 09/2006 - 03/2002
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	BM 27IBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	palbociclibIBA 11/2021
1	NivolumabIBA 11/2021
1	Capecitabine (Xeloda)FDA Link 05/2021
1	Ado-Trastuzumab EmtansineIBA 03/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	trametinibIBA 01/2021
1	dabrafenibIBA 01/2021
1	ceritinibIBA 01/2021
1	Sunitinib (Sutent)FDA Link 01/2021
1	Melanoma-Specific AntigensIBA 01/2021
1	UbiquitinIBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	MK 2206IBA 07/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 10/2019
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 06/2019
1	Methotrexate (Mexate)FDA LinkGeneric 06/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	Small Interfering RNA (siRNA)IBA 05/2018
1	N 30IBA 06/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	OvalbuminIBA 02/2016
1	Formaldehyde (Formol)FDA Link 01/2016
1	ParaffinIBA 01/2016

Therapy/Procedure

32	Therapeutics 01/2022 - 03/2005
16	Immunotherapy 01/2022 - 05/2005
11	Neoadjuvant Therapy 01/2022 - 04/2005
10	Radiotherapy 01/2022 - 01/2005
8	Segmental Mastectomy (Lumpectomy) 03/2018 - 02/2004
7	Drug Therapy (Chemotherapy) 01/2022 - 04/2005
6	Mastectomy (Mammectomy) 06/2017 - 08/2003
4	Aftercare (After-Treatment) 03/2021 - 04/2004
2	Adjuvant Radiotherapy 09/2019 - 06/2017
2	Castration 01/2015 - 12/2014
2	Lymph Node Excision (Lymph Node Dissection) 09/2013 - 06/2005
2	Mammaplasty (Breast Reconstruction) 07/2013 - 06/2013
1	Chemoprevention 01/2021
1	Surgical Instruments (Clip) 01/2021